2020. A randomized controlled trial to compare the efficacy and safety of glycopyrronium bromide + salmeterol/fluticasone and tiotropium bromide + salmeterol/fluticasone in chronic obstructive pulmonary disease. Innovative Journal of Medical and Health Sciences. 10, 05 (May 2020), 853–857.